Welcome to our dedicated page for National Healthcare Properties SEC filings (Ticker: NHPBP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The NHPBP SEC filings page focuses on regulatory documents for National Healthcare Properties, Inc. 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock and its issuer, National Healthcare Properties, Inc. As a Maryland-incorporated real estate investment trust, NHP files periodic and current reports with the U.S. Securities and Exchange Commission that describe its healthcare real estate operations, capital structure and governance. These filings cover the REIT’s seniors housing and outpatient medical facility portfolio, organized into Senior Housing Operating Property (SHOP) and Outpatient Medical Facility (OMF) segments.
Key filings include Form 10-K annual reports and Form 10-Q quarterly reports, which provide audited and interim financial statements, segment information, risk factors and detailed discussions of non-GAAP measures such as Funds from Operations (FFO), Adjusted Funds from Operations (AFFO), NOI, Cash NOI and Adjusted EBITDA. These documents help investors understand how NHP evaluates the performance of its healthcare real estate portfolio and supports obligations on its preferred stock, including NHPBP.
Form 8-K current reports are particularly relevant for NHPBP holders. Recent 8-Ks describe material events such as the entry into a senior unsecured credit agreement, amendments to a rights agreement, board declassification actions, bylaw amendments addressing universal proxy rules and proxy access, and the appointment of key executives and independent directors. These filings also document the declaration of dividends on the 7.125% Series B preferred stock and other preferred series.
On Stock Titan, SEC filings for NHP and NHPBP are updated from the EDGAR system and paired with AI-powered summaries that highlight the most important points, such as changes in leverage, new financing arrangements, governance modifications and preferred stock terms. Users can also review equity-related filings, including descriptions of the 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, along with any future Forms 4 that may report insider transactions in the company’s securities.
National Healthcare Properties, Inc. entered into a new unsecured credit agreement on December 11, 2025, for a $400 million revolving credit facility and a $150 million term loan. These credit facilities, guaranteed by the company and certain subsidiaries, replace a prior secured term loan that was paid off at closing.
The facilities mature on December 11, 2028, with options to extend for up to two additional one-year periods, and may be increased by up to $450 million subject to conditions. Borrowings will bear interest at either a base rate plus a margin of 0.55%–1.10% or Daily Simple SOFR/Term SOFR plus 1.55%–2.10%, based on consolidated leverage. The company plans to use the credit facilities for general corporate and working capital purposes, including debt repayment, real estate acquisitions, development costs and capital expenditures.
National Healthcare Properties, Inc. entered into a new unsecured credit agreement on December 11, 2025, for a $400 million revolving credit facility and a $150 million term loan. These credit facilities, guaranteed by the company and certain subsidiaries, replace a prior secured term loan that was paid off at closing.
The facilities mature on December 11, 2028, with options to extend for up to two additional one-year periods, and may be increased by up to $450 million subject to conditions. Borrowings will bear interest at either a base rate plus a margin of 0.55%–1.10% or Daily Simple SOFR/Term SOFR plus 1.55%–2.10%, based on consolidated leverage. The company plans to use the credit facilities for general corporate and working capital purposes, including debt repayment, real estate acquisitions, development costs and capital expenditures.
National Healthcare Properties, Inc. filed an initial Form 3 for its Chief Financial Officer, indicating their status as an officer subject to Section 16 reporting. The filing states that the reporting person does not beneficially own any non-derivative or derivative securities of the company. The form is filed by one reporting person, with a power of attorney documented as Exhibit 24.1, and relates to an event dated 11/18/2025.
National Healthcare Properties, Inc. filed an initial Form 3 for its Chief Financial Officer, indicating their status as an officer subject to Section 16 reporting. The filing states that the reporting person does not beneficially own any non-derivative or derivative securities of the company. The form is filed by one reporting person, with a power of attorney documented as Exhibit 24.1, and relates to an event dated 11/18/2025.
National Healthcare Properties, Inc. announced a leadership change in its finance organization. On November 18, 2025, the Board appointed Andrew T. Babin as Chief Financial Officer and Treasurer, replacing Scott M. Lappetito, who resigned the same day and whose resignation was stated not to result from any disagreement on management, operations or financial matters.
Under his employment agreement, Mr. Babin will receive an annual base salary of $400,000, a target annual bonus of $350,000 (prorated for 2025), and, for fiscal 2026, eligibility for long-term equity awards with a target grant date fair value of at least $600,000, split between time-based restricted shares and performance-based restricted stock units. He will also receive a one-time time-based restricted stock award with a grant date fair value of $200,000 that vests over three years.
If Mr. Babin resigns for Good Reason or is terminated without Cause outside a change in control period, he is entitled to base benefits plus a cash severance equal to 1.0x his then-current base salary paid over 24 months and up to 12 months of healthcare premium reimbursement; during a change in control period, the severance increases to 2.0x his then-current base salary plus target bonus, paid in a lump sum, with full vesting of time-based equity. Mr. Lappetito’s separation agreement provides cash equal to his 2025 base salary and target bonus plus his guaranteed 2025 target bonus, full vesting of time-based equity, continued vesting of a prorated portion of performance-based equity, and up to 18 months of COBRA premium payments, alongside non-compete and non-solicitation covenants.
National Healthcare Properties, Inc. announced a leadership change in its finance organization. On November 18, 2025, the Board appointed Andrew T. Babin as Chief Financial Officer and Treasurer, replacing Scott M. Lappetito, who resigned the same day and whose resignation was stated not to result from any disagreement on management, operations or financial matters.
Under his employment agreement, Mr. Babin will receive an annual base salary of $400,000, a target annual bonus of $350,000 (prorated for 2025), and, for fiscal 2026, eligibility for long-term equity awards with a target grant date fair value of at least $600,000, split between time-based restricted shares and performance-based restricted stock units. He will also receive a one-time time-based restricted stock award with a grant date fair value of $200,000 that vests over three years.
If Mr. Babin resigns for Good Reason or is terminated without Cause outside a change in control period, he is entitled to base benefits plus a cash severance equal to 1.0x his then-current base salary paid over 24 months and up to 12 months of healthcare premium reimbursement; during a change in control period, the severance increases to 2.0x his then-current base salary plus target bonus, paid in a lump sum, with full vesting of time-based equity. Mr. Lappetito’s separation agreement provides cash equal to his 2025 base salary and target bonus plus his guaranteed 2025 target bonus, full vesting of time-based equity, continued vesting of a prorated portion of performance-based equity, and up to 18 months of COBRA premium payments, alongside non-compete and non-solicitation covenants.
National Healthcare Properties, Inc. furnished a current report announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The company stated the information under Item 2.02 and Exhibit 99.1 is being furnished, not filed, under the Securities Exchange Act of 1934. The filing also lists the company’s preferred stock listings: 7.375% Series A (NHPAP) and 7.125% Series B (NHPBP) on The Nasdaq Global Market.
National Healthcare Properties, Inc. furnished a current report announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The company stated the information under Item 2.02 and Exhibit 99.1 is being furnished, not filed, under the Securities Exchange Act of 1934. The filing also lists the company’s preferred stock listings: 7.375% Series A (NHPAP) and 7.125% Series B (NHPBP) on The Nasdaq Global Market.
National Healthcare Properties, Inc. reported a narrower quarterly loss while continuing to streamline its balance sheet. For Q3, revenue from tenants was $86.0 million versus $88.9 million a year ago, and net loss attributable to common stockholders was $15.9 million (basic and diluted EPS $(0.56)), improving from $44.1 million last year. Year to date, revenue from tenants was $257.8 million, with a net loss attributable to common stockholders of $45.1 million.
Total assets were $1.74 billion, down from $1.95 billion at year-end, reflecting property sales and lower real estate balances. Net real estate investments declined to $1.54 billion. Debt balances included mortgage notes payable, net of $696.8 million, and Fannie Mae secured debt of $336.2 million. Operating expenses benefited from the absence of related-party operating and termination fees seen in 2024, partially offset by $6.6 million of Q3 impairment charges. The company recorded a Q3 gain on sale of real estate of $0.6 million and year-to-date gains of $28.3 million.
Cash from operations was a modest use of $3.0 million year to date, while investing provided $73.1 million (driven by $90.3 million of sale proceeds). Financing used $41.7 million, including debt repayments and preferred stock repurchases. As of October 30, 2025, common shares outstanding were 28,426,694.
National Healthcare Properties, Inc. reported a narrower quarterly loss while continuing to streamline its balance sheet. For Q3, revenue from tenants was $86.0 million versus $88.9 million a year ago, and net loss attributable to common stockholders was $15.9 million (basic and diluted EPS $(0.56)), improving from $44.1 million last year. Year to date, revenue from tenants was $257.8 million, with a net loss attributable to common stockholders of $45.1 million.
Total assets were $1.74 billion, down from $1.95 billion at year-end, reflecting property sales and lower real estate balances. Net real estate investments declined to $1.54 billion. Debt balances included mortgage notes payable, net of $696.8 million, and Fannie Mae secured debt of $336.2 million. Operating expenses benefited from the absence of related-party operating and termination fees seen in 2024, partially offset by $6.6 million of Q3 impairment charges. The company recorded a Q3 gain on sale of real estate of $0.6 million and year-to-date gains of $28.3 million.
Cash from operations was a modest use of $3.0 million year to date, while investing provided $73.1 million (driven by $90.3 million of sale proceeds). Financing used $41.7 million, including debt repayments and preferred stock repurchases. As of October 30, 2025, common shares outstanding were 28,426,694.